CD133+ cancer stem-like cells in small cell lung cancer are highly tumorigenic and chemoresistant but sensitive to a novel neuropeptide antagonist. (2014)
Attributed to:
A hub for Engineering and exploiting the stem cell niche
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1158/0008-5472.can-13-1541
PubMed Identifier: 24436149
Publication URI: http://europepmc.org/abstract/MED/24436149
Type: Journal Article/Review
Volume: 74
Parent Publication: Cancer research
Issue: 5
ISSN: 0008-5472